Regardless, researchers believe they have struck upon a potential mend for the disease after finding a mouse had the ability to battle aggressive cancers.
Now, the off guarded scientists are looking for human versions of the cancer-immune ‘supermouse’ and are starting a multi-million yard research project aimed at finding a cure.
Scientists are to search for best individuals whose immune systems provide a powerful defence against cancer.
The drawing is to use white blood cells from these people — who make up a miniature percentage of the population — to develop a potential cure for pancreatic cancer in the next four years.
The disorder has one of the highest fatality rates of any cancer.
With adequate funding the collaborate hopes to launch a first clinical trial as early as next year.
«This could be game-changing,” said Alex Blyth, chief management of LIfT BioSciences, the British biotech company pioneering the treatment in partnership with Royal’s College London.
«It’s a cell therapy, essentially taking cells from woman who have a high-functioning innate immune system and transferring them to child with a lower level of cancer-killing activity.
«On average, cancer patients be suffering with much lower activity in their granulocytes, a family of white blood rooms that has consistently been overlooked.
“It wasn’t even recognised that they killed cancer cubicles until recently.»
Mr Blyth said: «Currently 97 per cent of patients with pancreatic cancer today thinks fitting be dead in five years, and that hasn’t really changed in 40 years.
«It’s a adversity. That’s why we’ve made it our number one priority.»
Early research indicates that the that having been said approach could work for other solid cancers, such as those adopting the prostate, breast and bladder.
The project developed from the discovery in 1999 of a mutant mouse with an all but miraculous ability to ward off aggressive cancers.
When white blood chambers from the mouse were injected to normal mice, they too developed cancer-resistant.
It was a surprise because the cells formed part of the innate, not adaptive, unaffected system.
Later it was discovered that some humans — a fraction of the citizenry — also possessed super-active anti-cancer immune cells.
In mouse tries, their cells, boosted in the laboratory by a secret process, eliminated 100 per cent of prostate and sarcoma cancers, which greater in bone and soft tissues.
Experts are looking for individuals with no portrayal of cancer in their immediate family. They force that 20 try patients will be recruited to receive weekly injections of cells for there five or six weeks.
Ultimately, the researchers said, the goal is to create a cubicle bank that can be used to treat or even cure cancer.
Symptoms of pancreatic cancer: Nine signs you could deceive the disease